Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 23:16:1565385.
doi: 10.3389/fendo.2025.1565385. eCollection 2025.

The expression profiles and roles of microRNAs in cardiac glucose metabolism

Affiliations

The expression profiles and roles of microRNAs in cardiac glucose metabolism

Nan-Nan Shen et al. Front Endocrinol (Lausanne). .

Abstract

Background: MicroRNAs (miRNAs) are a class of endogenous, non-coding RNAs, that have been implicated in cardiovascular diseases. Recent studies have suggested that dysregulated miRNAs accumulate in the heart and may be associated with impaired cardiac glucose metabolism. However an inconsistent direction of expression was observed in the current available literature. The aim of this study was to characterize miRNA expression profiles associated with glucose metabolism, and to explore their potential as biomarkers for glucose metabolism disorders in diabetic cardiomyopathy (DCM).

Methods: A systematic search of electronic databases, including Embase, PubMed, and the Cochrane Library, was conducted until October 1, 2024. Studies reporting on miRNAs expression profiles that regulate glucose metabolism in the heart were selected for inclusion. Pooled results were presented as log10 odds ratios (logORs) with 95% confidence intervals (CIs), using random-effect models. Subgroup analyses were conducted based on species, region, and sample source. Analyses by species focused specifically on humans and mice. The quality of included articles was assessed using the modified Diagnostic Accuracy Study 2 (QUADAS-2) tool. All workflows, including abstract screening, full-text review, data extraction, and quality assessment, were independently performed by two reviewers.

Results: A total of 47 eligible articles were included in this study, identifying 70 dysregulated miRNAs. Further analysis revealed that compared with the non-DCM group, the DCM group exhibited differential miRNA expression, with 12 miRNAs consistently upregulated and 8 consistently downregulated. Among these miRNAs, miR-199a (logOR 4.59; 95% CI: 3.02-6.15) was the most upregulated and frequently reported (n=7 studies), while let-7 (logOR 4.48; 95% CI: 2.41-6.55) was the most downregulated (4 studies). Subgroup analysis indicated that miRNA-21 was the most upregulated in cardiac tissue, and miRNA-133 was the most downregulated in cardiomyocytes. Additionally, miRNA-21 was found to be the most upregulated across different species. In the region subgroups, miRNA-199a and miRNA-503 were the most upregulated and downregulated in Asian countries, whereas miRNA-378 was the most dysregulated in non-Asian countries.

Conclusion: In summary, this study identified 20 consistently dysregulated miRNAs assocaited with myocardial glucose metabolism. Six dysregulated miRNAs, including miRNA-199a, let-7, miRNA-21, miRNA-133, miRNA-503 and miRNA-378, have potential as candidate miRNA biomarkers of glycometabolism in the heart. These findings require further validation in future larger-scale studies.

Keywords: biomarker; glucose metabolism; heart; miRNAs; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of studies selection process for this systematic review.
Figure 2
Figure 2
Consistently upregulated miRNAs in overall analysis. miR: microRNA; No.: number of included studies.
Figure 3
Figure 3
Consistently downregulated miRNAs in overall analysis. miR: microRNA; No.: number of included studies.

Similar articles

References

    1. Dutka DP, Pitt M, Pagano D, Mongillo M, Gathercole D, Bonser RS, et al. Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol. (2006) 48:2225–31. doi: 10.1016/j.jacc.2006.06.078, PMID: - DOI - PubMed
    1. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. (2007) 115:3213–23. doi: 10.1161/CIRCULATIONAHA.106.679597, PMID: - DOI - PubMed
    1. Li J, Zhu H, Shen E, Wan L, Arnold JM, Peng T. Deficiency of rac1 blocks nadph oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes. Diabetes. (2010) 59:2033–42. doi: 10.2337/db09-1800, PMID: - DOI - PMC - PubMed
    1. Zhu L, Li D, Zhang X, Wan S, Liu Y, Zhang H, et al. Comparative efficacy on outcomes of c-cabg, opcab, and onbeat in coronary heart disease: A systematic review and network meta-analysis of randomized controlled trials. Int J surgery. (2023) 109:4263–72. doi: 10.1097/JS9.0000000000000715, PMID: - DOI - PMC - PubMed
    1. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. (2003) 107:3040–6. doi: 10.1161/01.CIR.0000072789.89096.10, PMID: - DOI - PubMed

Publication types

LinkOut - more resources